Full text is available at the source.
The gut microbiome in obesity: new horizons in personalized medicine
The gut microbiome in obesity and its potential for personalized treatment
AI simplified
Abstract
Disturbances in the intestinal microbiota are considered a key modifiable factor in obesity and metabolic disorders.
- Individuals with obesity may exhibit variability in their microbiota composition.
- Dysbiosis is associated with altered production of short-chain fatty acids and other microbial byproducts.
- Chronic inflammation from lipopolysaccharides may link dysbiosis to metabolic disorders.
- The gut microbiota may influence appetite regulation and eating behavior via the microbiota-gut-brain axis.
- Current diagnostic approaches for dysbiosis and potential personalized medicine strategies are being explored.
AI simplified